Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments

Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USACorrespondence: Ayşe Elif Özdener-PoyrazFairleigh Dickinson Unive...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Özdener-Poyraz AE, Slugocki M, Kalabalik-Hoganson J, Han J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	pre-exposure prophylaxis hiv prevention prep uptake medications Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/92042df1aef94f43bb66c0419b8c6887
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:92042df1aef94f43bb66c0419b8c6887
record_format	dspace
spelling	oai:doaj.org-article:92042df1aef94f43bb66c0419b8c68872021-12-02T10:17:57ZPre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments1179-1373https://doaj.org/article/92042df1aef94f43bb66c0419b8c68872020-07-01T00:00:00Zhttps://www.dovepress.com/pre-exposure-prophylaxis-prep-in-the-prevention-of-hiv-strategies-targ-peer-reviewed-article-HIVhttps://doaj.org/toc/1179-1373Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USACorrespondence: Ayşe Elif Özdener-PoyrazFairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, 230 Park Avenue, M-Sp1-01, Florham Park, NJ 07932, USATel +973-443-8211Email eozdener@fdu.eduAbstract: Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.Keywords: pre-exposure prophylaxis, HIV prevention, PrEP uptake, medicationsÖzdener-Poyraz AESlugocki MKalabalik-Hoganson JHan JDove Medical Pressarticlepre-exposure prophylaxishiv preventionprep uptakemedicationsImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 12, Pp 283-293 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	pre-exposure prophylaxis hiv prevention prep uptake medications Immunologic diseases. Allergy RC581-607
spellingShingle	pre-exposure prophylaxis hiv prevention prep uptake medications Immunologic diseases. Allergy RC581-607 Özdener-Poyraz AE Slugocki M Kalabalik-Hoganson J Han J Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
description	Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USACorrespondence: Ayşe Elif Özdener-PoyrazFairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, 230 Park Avenue, M-Sp1-01, Florham Park, NJ 07932, USATel +973-443-8211Email eozdener@fdu.eduAbstract: Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.Keywords: pre-exposure prophylaxis, HIV prevention, PrEP uptake, medications
format	article
author	Özdener-Poyraz AE Slugocki M Kalabalik-Hoganson J Han J
author_facet	Özdener-Poyraz AE Slugocki M Kalabalik-Hoganson J Han J
author_sort	Özdener-Poyraz AE
title	Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_short	Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_full	Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_fullStr	Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_full_unstemmed	Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_sort	pre-exposure prophylaxis (prep) in the prevention of hiv: strategies, target populations and upcoming treatments
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/92042df1aef94f43bb66c0419b8c6887
work_keys_str_mv	AT ozdenerpoyrazae preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments AT slugockim preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments AT kalabalikhogansonj preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments AT hanj preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments
_version_	1718397423738421248

Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments

Ejemplares similares